Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
1.64
-0.01 (-0.61%)
At close: May 26, 2022 3:24 PM
1.72
0.08 (4.88%)
After-hours:May 26, 2022 6:49 PM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|
Market Capitalization | 17 | 36 | 92 | 49 | 88 | 35 | 62 |
Market Cap Growth | - | -60.62% | 87.50% | -44.07% | 149.56% | -43.39% | - |
Enterprise Value | 11 | 30 | 104 | 60 | 96 | 43 | 70 |
PE Ratio | - | -22.51 | -50.45 | -14.33 | -19.81 | -4.99 | -2.40 |
PB Ratio | 2.83 | 5.51 | -6.72 | -4.14 | -10.21 | -4.19 | -7.43 |
Debt / Equity Ratio | - | 0 | -0.86 | -0.95 | -1.05 | -0.98 | -1.05 |
Debt / EBITDA Ratio | - | 0 | -14.21 | -4.63 | -2.81 | -3.13 | -0.38 |
Debt / FCF Ratio | - | 0 | -27.46 | -3.48 | -2.19 | -2.47 | -1.20 |
Current Ratio | 110.97 | 66.81 | 0 | 0.05 | 0.11 | 0.83 | 0.47 |
Return on Equity (ROE) | - | 17.30% | 14.00% | 31.10% | 52.50% | 74.60% | 436.00% |
Return on Assets (ROA) | -58.30% | -94.70% | -67220.10% | -1006.80% | -418.00% | -482.60% | -1146.30% |
Return on Capital (ROIC) | - | 46.90% | 55.50% | -108.40% | -53.70% | -48.00% | -496.70% |
Earnings Yield | -10.94% | -4.44% | -1.98% | -6.98% | -5.05% | -20.05% | -41.66% |
FCF Yield | -11.48% | -3.39% | -0.46% | -6.62% | -4.68% | -9.47% | -11.79% |
Buyback Yield / Dilution | -255.53% | -56.01% | 0.17% | -45.07% | -29.09% | -3.46% | -32.21% |
Total Shareholder Return | -255.53% | -56.01% | 0.17% | -45.07% | -29.09% | -3.46% | -32.21% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).